Microbiology Operations & Time Optimization in Sepsis

NCT07817043 · tracked via the Priya Life Science Germany tracker

Sponsor

University Medicine Greifswald

Phase

Observational

Started

2026-10-01

Last updated

2026-09-14

Condition(s) studied

SepsisBloodstream InfectionBacterial InfectionsSeptic ShockBacteremia

Investigational drug(s) / intervention(s)

laboratory infrastructure

laboratory infrastructure: will follow

Study summary

The goal of this study is to simulate turn-around times of blood cultures from blood culture collection to final communication of the result. The main objective is to develop a web-based tool that is able to simulate heterogeneous laboratory settings and to analyse the impact of infrastructure and opening hours on blood culture turn-around times.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

microbiological laboratories conducting blood culture analysis

Primary outcome measure(s)

Turn-around time — 4 weeks for the conduction of the simulation

Trial sites (1)

Facility	City	Region	Status
University Medicine Greifswald	Greifswald	Germany

More University Medicine Greifswald trials in Germany

Acceptance of Mandibular Advancement Devices Enrolling by invitation

Transcranial Direct Current Stimulation to Enhance Training Effectiveness in Chronic Post-Stroke Aphasia Active, not recruiting

Evaluation of Solanidine as an Exogenous Biomarker to Phenotype CYP2D6 Activity in Humans Starting soon

A Comparison of Fisetin Kinetics in Young and Old Adults Recruiting

Acupuncture Mechanism in Relief of Gag Reflex Recruiting

Other trials for the same condition

A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy Recruiting

Remote Ischemic Preconditioning in Septic Patients Recruiting

Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis Starting soon

ARTICE® Real Data Collection & Observational Trial, Phase 4 Study Recruiting

Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07817043 on ClinicalTrials.gov ↗ ← All trials in Germany